Crossmark

Ebola viral receptor Niemann–Pick C1 (NPC1) in human cancers: a potential biomarker and immunotherapeutic target

Published Online: 2021-10-22

Published Print: 2022-01

Authors

Fang, Zhen https://orcid.org/0000-0002-7073-8997
Li, Peijuan

Shang, Liang

Li, Fei https://orcid.org/0000-0002-6402-6811
Funding

Funding for this research was provided by:

Beijing Municipal Science & Technology Commission (Z171100001017077)

Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support (XMLX201404)

Capital Medical Development and Research Special Project (2020-1-2012)
License Information

Text and Data Mining valid from 2021-10-22

Version of Record valid from 2021-10-22
More Information

Article History

Received: 24 September 2021

Accepted: 16 October 2021

First Online: 22 October 2021

Declarations

:

: Not applicable.

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current